2000
DOI: 10.1001/archderm.136.4.487
|View full text |Cite
|
Sign up to set email alerts
|

Lower Relapse Rate of Botulinum Toxin A Therapy for Axillary Hyperhidrosis by Dose Increase

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
31
0
2

Year Published

2000
2000
2017
2017

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 72 publications
(36 citation statements)
references
References 27 publications
3
31
0
2
Order By: Relevance
“…[46] Studies examining BTX-A therapy specifically for axillary HH have used varying doses, typically ranging between 50 and 100 U of Botox Ò per axilla. Although two uncontrolled, non-comparative studies of high-dose BTX-A (200 U of Botox Ò in each axilla) described efficacy for as long as 29 months, [140,191] most other studies suggest little significant improvement with dosing >50 U per axilla. [56,85,[144][145][146] One large randomized, double-blind, placebocontrolled, multicenter trial comparing 50 U and 75 U Botox Ò with placebo found no significant difference in the efficacy or duration of action with the higher Botox Ò dosage, and both doses were significantly better than placebo.…”
Section: Axillary Hhmentioning
confidence: 99%
“…[46] Studies examining BTX-A therapy specifically for axillary HH have used varying doses, typically ranging between 50 and 100 U of Botox Ò per axilla. Although two uncontrolled, non-comparative studies of high-dose BTX-A (200 U of Botox Ò in each axilla) described efficacy for as long as 29 months, [140,191] most other studies suggest little significant improvement with dosing >50 U per axilla. [56,85,[144][145][146] One large randomized, double-blind, placebocontrolled, multicenter trial comparing 50 U and 75 U Botox Ò with placebo found no significant difference in the efficacy or duration of action with the higher Botox Ò dosage, and both doses were significantly better than placebo.…”
Section: Axillary Hhmentioning
confidence: 99%
“…[30][31][32][33] The medical applications were first hypothesized by Justinus Kerner around 1820 in his description of food-borne botulinum. 34 Botulinum toxin A acts by blocking the release of acetylcholine from the presynaptic terminal of the neuromuscular junction.…”
Section: Discussionmentioning
confidence: 99%
“…The effect of botulinum toxin A is dose-dependent, with higher doses producing longer remission of symptom up to 7-15 months. 33 We also studied the histological effects of botulinum toxin A in different tissues of cats by immunochemistry for neurofilament and SNAP-25. Injection of higher doses of BTA consistently had longer effect than the lower doses (data unpublished).…”
Section: Discussionmentioning
confidence: 99%
“…Intermediate doses of 50-100 U of Botox ® produce a duration of about 9-12 months, whereas higher doses of 200 U of Botox ® produce an anhidrotic effect in a part of patients than can last longer than 15 months. [1112]…”
Section: Btx: Effects On Exocrine Glandsmentioning
confidence: 99%